Apoptosis after experimental stroke: Fact or fashion?

Journal of Neurotrauma

Volumn 17, Issue 10, 2000, Pages 899-914

  MacManus, J P ^a   Buchan, A M ^b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Apoptosis; Brain ischemia; Gene expression; Necrosis; Neuronal cell death; Stroke

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CELL AGING; DISEASE MODEL; ENERGY EXPENDITURE; ENZYME ACTIVITY; GENE EXPRESSION; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW; STROKE;

EID: 0033782416     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2000.17.899     Document Type: Review

References (170)

1. Translocation of cytochrome C following transient global ischemia in the gerbil
2. Bcl-xL Bax interaction after transient global ischemia
3. Expression of interleukin-1 beta converting enzyme gene family and bcl-2 gene family in the rat brain following permanent occlusion of the middle cerebral artery
4. Chronic cerebral hypofusion elicits neuronal apoptosis and behavioral impairment
5. Defects in regulation of apoptosis in caspase-2 deficient mice
6. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain
7. Increased expression of IL-1β converting enzyme in hippocampus after ischemia: Selective localization in microglia
8. Anoxic-ischmic cell change in rat brain: Light microscopic and fine-structural observations
9. Induction of interleukin-1β mRNA after focal cerebral ischemia in the rat
10. Early endonuclease activation following reversible focal ischemia in the rat brain
11. Apoptosis and necrosis after reversible focal ischemia: An in situ DNA fragmentation analysis
12. DNA damage and DNA damage-inducible protein Gadd45 following ischemia in the P7 neonatal rat
13. Bcl-2 is expressed in neurons that survive focal ischemia in the rat
14. Apoptosis repressor genes Bcl-2 and Bcl-x-long are expressed in the rat brain following global ischemia
15. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia
16. Expression of the apoptosis-effector gene, Bax is up-regulated in vulnerable hippocampal CA1 neurons following global ischemia
17. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury
18. Apoptosis in focal cerebral ischemia
19. P53 expression in brain after middle cerebral artery occlusion in the rat
20. Developmental cell death: Morphological diversity and multiple mechanisms
21. Continuing postischemic neuronal death in CA1: Influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats
22. Electron microscopic evidence against apoptosis as the mechanism of neuronal death in global ischemia
23. The problem of assessing effective neuroprotection in experimental cerebral ischemia
24. Attenuation of p53 expression protects against focal ischemic damage in transgenic mice
25. Cell death is prevented in thalamic fields but not in injured neocortical areas after permanent focal ischaemia in mice overexpressing the anti-apoptotic protein Bcl-2
26. Ultrastructural changes in the hippocampus CA1 region following transient cerebral ischemia: Evidence against programmed cell death
27. IAP family proteins - Suppressors of apoptosis
28. Pathobiology of ischaemic stroke: An integrated view
29. Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis?
30. Estradiol modulates bcl-2 in cerebral ischemia: A potential role for estrogen receptors
31. Apoptosis in perinatal hypoxic-ischaemic cerebral damage
32. Caspase pathways, neuronal apoptosis and CNS injury
33. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family
34. The time-course of DNA fragmentation in the choroid plexus and the CA1 region following transient global ischemia in the rat brain: The effect of intra-ischemic hypothermia
35. Cell death in the normal developing brain, and following ionizing radiation, methyl-azoxymethanol acetate, and hypoxia-ischaemia in the rat
36. Evidence of nuclear DNA fragmentation following hypoxia-ischemia in the infant rat brain, and transient forebrain ischemia in the adult gerbil
37. Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation
38. Mitochondrial participation in ischemic and traumatic neural cell death
39. Mitochondria in neurodegeneration: Acute ischemia and chronic neurodegenerative diseases
40. Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerability
41. Expression of a dominant negative mutant of interleukin-1β converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury
42. Cytosolic redistribution of cytochrome C after transient focal cerebral ischemia in rats
43. Novel non-apoptotic morphological changes in neurons of the mouse hippocampus following transient hypoxic-ischemia
44. Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex
45. Activation of CPP-32 protease in hippocampal neurons following ischemia and epilepsy
46. Inhibition of caspases prevents cell death of hippocampal CA1 neurons, but not impairment of hippocampal long-term potentiation following global ischemia
47. Altered expression of Bcl-2, Bcl-X, Bax, and c-Fos colocalizes with DNA fragmentation and ischemic cell damage following middle cerebral artery occlusion in rats
48. Expression of cell death-associated phospho-c-Jun and p53-activated gene 608 in hippocampal CA1 neurons following global ischemia
49. Bcl-2 family gene products in cerebral ischemia and traumatic brain injury
50. Bcl-2 family members and the mitochondria in apoptosis
51. HIF-1α and p53 promote hypoxia-induced delayed neuronal death in models of CNS injury
52. Hypoxia-inducible factor-1α mediates hypoxia-induced delayed neuronal death that involves p53
53. Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage
54. Attenuation of transient focal cerebral ischemia injury in transgenic mice expressing a mutant ICE inhibitory protein
55. Immunohistochemical detection of Bax and Bcl-2 proteins in gerbil hippocampus following transient forebrain ischemia
56. Hypothermic prevention of nuclear DNA fragmentation in gerbil hippocampus following transient forebrain ischemia
57. The use of quantitative RT-PCR to measure mRNA expression in a rat model of focal ischemia - Caspase-3 as a case study
58. Targeted disruption of the bcl-2 gene in mice exacerbates focal ischemic brain injury
59. Regional variability in DNA fragmentation after global ischemia evidenced by combined histological and gel electrophoresis observations in the rat brain
60. DNA fragmentation indicative of apoptosis following unilateral cerebral hypoxia-ischemia in the neonatal rat
61. A caspase inhibitor blocks ischemia-induced delayed neuronal death in the gerbil
62. Mitochondrial permeability transition in apoptosis and necrosis
63. Global ischemia induces apoptosis-associated genes in hippocampus
64. Increases in DNA-lesions and the DNA damage indicator Gadd45 following transient cerebral ischemia
65. Differential regulation of Bax, Bcl-2 and Bcl-x proteins in focal cortical ischemia in the rat
66. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain
67. Temporal profile of nuclear DNA fragmentation in situ in gerbil hippocampus following transient forebrain ischemia
68. DNA fragmentation in the CA2 sector of gerbil hippocampus following transient forebrain ischemia
69. Focal ischemia induces expression of the DNA damage-inducible gene GADD45 in the rat brain
70. Poly(ADP ribose) polymerase cleavage precedes neuronal death in the hippocampus and cerebellum following injury to the developing rat forebrain
71. Visualization of DNA double strand breaks in the gerbil hippocampus CA1 following transient ischemia
72. Upregulation of the Nedd2 gene encoding an ICE/Ced-3 like cysteine protease in the gerbil brain after transient global ischemia
73. Fine structural nature of delayed neuronal death following ischemia in the gerbil hippocampus
74. Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of Bcl-2 in transgenic mice
75. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia
76. Upregulation of Bax protein levels in neurons following cerebral ischemia
77. Overexpression of Bcl-2 with herpes simplex vectors protects CNS neurons against neurological insults in vitro and in vivo
78. Herpes simplex viral vectors expressing Bxl-2 are neuroprotective when delivered after a stroke
79. The changing landscape of ischaemic brain injury mechanisms
80. The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy
81. Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats
82. Increased expression of apoptosis-linked gene 2 (ALG-2) in the rat brain after temporary focal cerebral ischemia
83. Granule cell apoptosis and protein expression in hippocampal dentate gyrus after forebrain ischemia in rat
84. p53 immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats
85. Temporal profile of in situ DNA fragmentation after transient middle cerebral artery occlusion in the rat
86. Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat
87. Intact, injured, necrotic and apoptotic cells after focal cerebral ischemia in the rat
88. Apoptotic DNA fragmentation in the rat cerebral cortex induced by permanent middle cerebral artery occlusion
89. Expression of Bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal ischemia
90. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats
91. Ischemic cell death in brain neurons
92. Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage
93. An ICE inhibitor, z -VAD-DCB attenuates ischaemic brain damage in the rat
94. Neuronal death in brain infarcts in man
95. Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischemia in mice
96. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain
97. DNA damage consistent with apoptosis in transient focal ischaemic neocortex
98. Cerebral ischemia produces laddered DNA fragments distinct from cardiac ischemia and archetypal apoptosis
99. Differences in DNA fragmentation following transient cerebral or decapitation ischemia in rats
100. Decreased brain infarct following focal ischemia in mice lacking the transcription factor E2F1
101. Gene expression induced by cerebral ischemia: An apoptotic perspective
102. Ischemic Neuronal death is not by classic apoptosis: Are all DNA-ladders the same?
103. Detection of higher-order 50- and 10-kbp DNA fragments before apoptotic internucleosomal cleavage following transient cerebral ischemia
104. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis
105. Apoptosis and necrosis occur in separate neuronal populations in hippocampus and cerebellum after ischemia and are associated with differential alterations in metabotropic glutamate receptor signaling pathways
106. Overexpression of Bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia
107. Blockade of the mitochondrial permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion
108. Alterations of Bcl-2 family proteins precede cytoskeletal proteolysis in the penumbra, but not in infarct centres following focal cerebral ischemia in mice
109. Hippocampal Myc and p53 expression following transient global ischemia
110. Neuropharmacological aspects of apoptosis: Significance for neurodegenerative diseases
111. Bcl-w expression is increased in brain regions affected by focal cerebral ischemia in the rat
112. Mitochondria in neurodegeneration: Bioenergetic function in cell life and death
113. Apoptotic DNA fragmentation
114. Up-regulation of c-myc gene expression following focal ischemia in the rat brain
115. Release of cytochrome C from mitochondria to cytosol in gerbil hippocampal CA1 neurons after transient forebrain ischemia
116. Cytochrome C release from mitochondria to the cytosol was suppressed in the ischemia-tolerance-induced hippocampal CA1 region after 5-min forebrain ischemia in gerbils
117. Activation and cleavage of Caspase-3 in apoptosis induced by experimental cerebral ischemia
118. Transient forebrain global ischemia induces a prolonged expression of the caspase 3 mRNA in rat hippocampal CA1 neurons
119. Caspase structure, proteolytic substrates, and function during apoptotic cell death
120. Apoptosis in neural development and disease
121. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis
122. Internucleosomal DNA cleavage involved in ischemia-induced neuronal death
123. Release of mitochondrial aspartate aminotransferase (mAST) following transient focal cerebral ischemia suggests the opening of a mitochondrial permeability transition pore
124. Survival- and death-promoting events after transient cerebral ischemia: Phosphorylation of Akt, release of cytochrome c, and activation of caspase-like proteases
125. The effects of N-methyl-N-nitorosourea and azoxymethane on focal cerebral infarction and the expression of p53, p21 proteins
126. Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons
127. Cytochrome c is released from mitochondria into the cytosol after cerebral anoxia or ischemia
128. Recent advances on the pathogenesis of Huntington's disease
129. Delayed neuronal recovery and neuronal death in rat hippocampus following severe cerebral ischemia: Possible relationships to abnormalities in neuronal processes
130. DNA fragmentation follows delayed neuronal death in CA1 neurons exposed to transient global ischemia in the rat
131. Limitations in the neuroprotective potential of gene therapy with Bcl-2
132. A model of transient unilateral focal ischemia with reperfusion in the P7 neonatal rat
133. Neuronal apoptosis in acute necrotic insults: Why is this subject such a mess?
134. Reduced ischemic brain injury in interleukin-1b converting enzyme-deficient mice
135. Caspases as treatment targets in stroke and neurodegenerative diseases
136. Internucleosomal DNA fragmentation in gerbil hippocampus following forebrain ischemia
137. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor
138. Increase in Bcl-2 oncoprotein and the tolerance to ischemia-induced neuronal death in the gerbil hippocampus
139. Nuclear condensation and fragmentation following cerebral hypoxia-ischemia occurs more frequently in immature than older rats
140. The interleukin-1β-converting enzyme (ICE) is localised on the external surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy
141. The cellular response to p53: The decision between life and death
142. Serial killers: Ordering caspase activation events in apoptosis
143. DNA fragmentation and HSP70 protein induction in hippocampus and cortex occurs in separate neurons following permanent middle cerebral arter occlusions
144. Mitochondrial release of cytochrome C corresponds to the selective vulnerability of hippocampal CA1 neurons in rats after transient global cerebral ischemia
145. Apoptotic mechanisms in neurodegeneration: Possible relevance to glaucoma
146. Oxidative metabolism, apoptosis and perinatal brain injury
147. The tumor suppressor p53 and its response gene p21(WAF/Cip1) are not markers of neuronal death following transient global cerebral ischemia
148. Activation of p53 and its target genes p21(WAF/Cip1) and PAG608/Wig-1 in ischemic preconditioning
149. Endonuclease activation following focal ischemic injury in the rat brain
150. Bcl-2 family: Life-or-death switch
151. Elevated Mdm2 expression in rat brain following transient middle cerebral artery occlusion
152. Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat
153. Ultrastructural morphological changes are not characteristic of apoptotic cell death following focal cerebral ischaemia in the rat
154. Cell cycle-related gene expression in the adult rat brain: Selective induction of cyclin G1 and p21(WAF/Cip1) in neurons following focal cerebral ischemia
155. Increased expression of cyclin G1 and p21(WAF/CIP1) in neurons following transient forebrain ischemia: Comparison with early DNA damage
156. Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat
157. Neither caspase-3 nor DNA fragmentation factor is required for high molecular weight DNA degradation in apoptosis
158. Differential effects of Bcl-2 overexpression on hippocampal CA1 neurons and dentate granule cells following hypoxic ischemia in adult mice
159. Increase in p53 protein expression following cortical infarction in the spontaneously hypertensive rat
160. Neuron-specific transgene expression of Bcl-xL but not Bcl-2 genes reduced lesion size after permanent middle cerebal artery occlusion in mice
161. Protective effect of a caspase inhibitor in models for cerebral ischemia in vitro and in vivo
162. Expression of transforming growth factor β1 and interleukin-1β mRNA in rat brain following transient forebrain ischemia
163. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus
164. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hipocampus
165. DNA cleavage and proteolysis of microtubule-associated protein 2 after cerebral ischemia of different severity
166. Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia
167. Quantitation of multiple gene expression by in situ hybridization autoradiography: Accurate normalization using Bayes classifier
168. Regional and temporal alterations in DNA fragmentation factor (DFF)-like proteins following experimental brain trauma in the rat
169. The beta(2)-adrenoceptor agonist clenbuterol modulates Bcl-2, Bcl-xl and Bax protein expression following transient forebrain ischemia